Lv3
238 积分 2024-07-07 加入
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
1年前
已完结
Anti-CD7 CAR T cells for T-ALL: impressive early-stage efficacy
1年前
已完结
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
1年前
已完结
Emerging trends in clinical allogeneic CAR cell therapy
1年前
已完结
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms
1年前
已完结
Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis
1年前
已完结
Characteristics of second primary malignancies following bispecific antibodies therapy
1年前
已完结
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study
1年前
已完结
皖公网安备34019202002308
